Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1707-1712

  Villa, Laura ^a   Feudi, Claudia ^a   Fortini, Daniela ^a   Garciá Fernández, Aurora ^a   Carattoli, Alessandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ERTAPENEM; IMIPENEM; MEROPENEM; NUCLEAR PROTEIN; RIBOSOMAL PROTEIN S10; RNA 16S; TIGECYCLINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; CLONE; ENTEROBACTER CLOACAE; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC DIFFERENCE; GENOME ANALYSIS; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; PULSED FIELD GEL ELECTROPHORESIS; RAMR GENE; RIBOSOME SUBUNIT; THERMUS THERMOPHILUS;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; KLEBSIELLA PNEUMONIAE; MINOCYCLINE; MOLECULAR SEQUENCE DATA; MUTATION; RIBOSOMAL PROTEINS;

EID: 84896866829     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01803-13     Document Type: Article

References (44)

1. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707. http://dx.doi.org/10.1128/CMR.05035-11.
2. van Duin D, Kaye KS, Neuner EA, Bonomo RA. 2013. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75:115-120. http://dx.doi.org/10.1016/j.diagmicrobio.2012.11.009.
3. Olson MW, Ruzin A, Feyfant E, Rush TS, III, O'Connell J, Bradford PA. 2006. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob. Agents Chemother. 50:2156-2166. http://dx.doi.org/ 10.1128/AAC.01499-05. (Pubitemid 43807538)
4. Pankey GA. 2005. Tigecycline. J. Antimicrob. Chemother. 56:470-480. http://dx.doi.org/10.1093/jac/dki248. (Pubitemid 41264122)
5. Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M, Blanchard SC, Wilson DN, Yusupova G. 2013. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc. Natl. Acad. Sci. U. S. A. 110:3812-3816. http://dx.doi.org/10.1073/pnas. 1216691110.
6. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB Network. 2013. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin. Microbiol Infect. 19:E23-E30. http://dx.doi.org/10.1111/1469-0691.12070.
7. Spanu T, De Angelis G, Cipriani M, Pedruzzi B, D'Inzeo T, Cataldo MA, Sganga G, Tacconelli E. 2012. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 56:4516-4518. http://dx.doi.org/10.1128/AAC.00234-12.
8. Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R; Survey Participants AMCLI-CRE, Pantosti A, Pagani L, Luzzaro F, Rossolini GM. 2013. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill. 18:pii:20489.
9. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, Giaquinta L, Valenti G, Romeo MA, Tsakris A. 2011. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J. Clin. Microbiol. 49:3986-3989. http://dx.doi.org/10.1128/JCM.01242-11.
10. Di Carlo P, Pantuso G, Cusimano A, D'Arpa F, Giammanco A, Gulotta G, Latteri AM, Madonia S, Salamone G, Mammina C. 2011. Two cases of monomicrobial intraabdominal abscesses due to KPC-3 Klebsiella pneumoniae ST258 clone. BMC Gastroenterol. 11:103. http://dx.doi.org/10.1186/1471-230X-11-103.
11. Fontana C, Favaro M, Sarmati L, Natoli S, Altieri A, Bossa MC, Minelli S, Leonardis F, Favalli C. 2010. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res. Notes 3:40. http://dx.doi.org/10.1186/1756-0500-3-40.
12. García-Fernández A, Villa L, Carta C, Venditti C, Giordano A, Venditti M, Mancini C, Carattoli A. 2012. Klebsiella pneumoniae ST258 producing KPC-3 identified in Italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob. Agents Chemother. 56:2143-2145. http://dx.doi.org/ 10.1128/AAC.05308-11.
13. Giani T, D'Andrea MM, Pecile P, Borgianni L, Nicoletti P, Tonelli F, Bartoloni A, Rossolini GM. 2009. Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J. Clin. Microbiol. 47:3793-3794. http://dx.doi.org/10.1128/JCM.01773-09.
14. Mammina C, Palma DM, Bonura C, Anna Plano MR, Monastero R, Sodano C, Calà C, Tetamo R. 2010. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in an intensive care unit in Italy. J. Clin. Microbiol. 48:1506-1507. http://dx.doi.org/10.1128/JCM.00315-10.
15. Marchese A, Coppo E, Barbieri R, Debbia E. 2010. Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. J. Chemother. 22:212-214. http://dx.doi.org/10.1179/joc.2010.22.3.212.
16. Mezzatesta ML, Gona F, Caio C, Petrolito V, Sciortino D, Sciacca A, Santangelo C, Stefani S. 2011. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin. Microbiol. Infect. 17:1444-1447. http://dx.doi.org/10.1111/j.1469-0691. 2011.03572.x.
17. Orsi GB, García-Fernández A, Giordano A, Venditti C, Bencardino A, Gianfreda R, Falcone M, Carattoli A, Venditti M. 2011. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J. Hosp. Infect. 78:54-58. http://dx.doi.org/10.1016/ j.jhin.2011.01.014.
18. Richter SN, Frasson I, Franchin E, Bergo C, Lavezzo E, Barzon L, Cavallaro A, Palù G. 2012. KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of nonintensive care units. Gut Pathog. 4:7. http://dx.doi.org/10.1186/1757-4749-4-7.
19. Ruzin A, Immermann FW, Bradford PA. 2008. Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52:3430-3432. http://dx.doi.org/10. 1128/AAC.00591-08.
20. Ruzin A, Visalli MA, Keeney D, Bradford PA. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump Acr-AB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49:1017-1022. http://dx.doi.org/10.1128/AAC.49.3.1017-1022.2005. (Pubitemid 40327718)
21. Nikaido H. 1996. Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178:5853-5859. (Pubitemid 26337766)
22. Keeney D, Ruzin A, Bradford PA. 2007. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug Resist. 13:1-6. http://dx.doi.org/10.1089/mdr.2006.9990. (Pubitemid 46833752)
23. Ruzin A, Keeney D, Bradford PA. 2005. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob. Agents Chemother. 49:791-793. http://dx.doi.org/10.1128/AAC.49.2.791-793.2005. (Pubitemid 40175699)
24. Visalli MA, Murphy E, Projan SJ, Bradford PA. 2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-396) in Proteus mirabilis. Antimicrob. Agents Chemother. 47: 665-669. http://dx.doi.org/10.1128/AAC.47.2.665-669.2003. (Pubitemid 36158098)
25. Bratu S, Landman D, George A, Salvani J, Quale J. 2009. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J. Antimicrob. Chemother. 64:278-283. http://dx.doi.org/10. 1093/jac/dkp186.
26. Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. 2010. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob. Agents Chemother. 54:2720-2723. http://dx.doi.org/10.1128/AAC.00085-10.
27. Rosenblum R, Khan E, Gonzalez G, Hasan R, Schneiders T. 2011. Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae. Int. J. Antimicrob. Agents 38:39-45. http://dx.doi.org/ 10.1016/j.ijantimicag.2011.02.012.
28. Veleba M, Schneiders T. 2012. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56:4466-4467. http://dx.doi.org/10.1128/AAC.06224-11.
29. Pérez A, Poza M, Aranda J, Latasa C, Medrano FJ, Tomás M, Romero A, Lasa I, Bou G. 2012. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob. Agents Chemother. 56:6256-6266. http://dx.doi.org/10.1128/ AAC.01085-12.
30. Roy S, Datta S, Viswanathan R, Singh AK, Basu S. 2013. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J. Antimicrob. Chemother. 68:1036-1042. http://dx.doi.org/ 10.1093/jac/dks535.
31. Liu P, Li P, Jiang X, Bi D, Xie Y, Tai C, Deng Z, Rajakumar K, Ou HY. 2012. Complete genome sequence of Klebsiella pneumoniae subsp. pneumoniae HS11286, a multidrug-resistant strain isolated from human sputum. J. Bacteriol. 194:1841-1842. http://dx.doi.org/10.1128/JB.00043-12.
32. Chmelnitsky I, Shklyar M, Hermesh O, Navon-Venezia S, Edgar R, Carmeli Y. 2013. Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258. J. Antimicrob. Chemother. 68:74-83. http://dx.doi.org/10.1093/jac/dks370.
33. Kumar V, Sun P, Vamathevan J, Li Y, Ingraham K, Palmer L, Huang J, Brown JR. 2011. Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. Antimicrob. Agents Chemother. 55:4267-4276. http://dx.doi.org/10.1128/AAC.00052-11.
34. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67:2640-2644. http://dx.doi.org/10. 1093/jac/dks261.
35. Bose M, Barber R. 2006. Prophage Finder: a prophage loci prediction tool for prokaryotic genome sequences. In Silico Biol. 6:0020.
36. Detweiler CS, Monack DM, Brodsky IE, Mathew H, Falkow S. 2003. virK, somA and rcsC are important for systemic Salmonella enterica serovar Typhimurium infection and cationic peptide resistance. Mol. Microbiol. 48:385-400. http://dx.doi.org/10.1046/j.1365-2958.2003.03455.x. (Pubitemid 36819076)
37. Majdalani N, Gottesman S. 2005. The Rcs phosphorelay: a complex signal transduction system. Annu. Rev. Microbiol. 59:379-405. http://dx.doi.org/10. 1146/annurev.micro.59.050405.101230. (Pubitemid 41507437)
38. Schleif R. 2010. AraC protein, regulation of the L-arabinose operon in Escherichia coli, and the light switch mechanism of AraC action. FEMS Microbiol. Rev. 34:779-796. http://dx.doi.org/10.1111/j.1574-6976.2010.00226.x.
39. Palaniyandi S, Mitra A, Herren CD, Lockatell CV, Johnson DE, Zhu X, Mukhopadhyay S. 2012. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073. PLoS One 7:e31348. http://dx.doi.org/10.1371/ journal.pone.0031348.
40. Pernestig AK, Georgellis D, Romeo T, Suzuki K, Tomenius H, Normark S, Melefors O. 2003. The Escherichia coli BarA-UvrY two-component system is needed for efficient switching between glycolytic and gluconeogenic carbon sources. J. Bacteriol. 185:843-853. http://dx.doi.org/10.1128/JB.185.3.843-853.2003. (Pubitemid 36139443)
41. Gallegos MT, Schleif R, Bairoch A, Hofmann K, Ramos JL. 1997. Arac/XylS family of transcriptional regulators. Microbiol. Mol. Biol. Rev. 61:393-410. (Pubitemid 28006953)
42. Luo X, Hsiao HH, Bubunenko M, Weber G, Court DL, Gottesman ME, Urlaub H, Wahl MC. 2008. Structural and functional analysis of the E. coli NusB-S10 transcription antitermination complex. Mol. Cell 32:791-802. http://dx.doi.org/10.1016/j.molcel.2008.10.028.
43. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Comparative Sequencing Program Group NISC, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med. 4:148ra116. http://dx.doi.org/10. 1126/scitranslmed.3004129.
44. Hu M, Nandi S, Davies C, Nicholas RA. 2005. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob. Agents Chemother. 49:4327-4334. http://dx.doi.org/10.1128/AAC.49.10.4327-4334.2005. (Pubitemid 41400980)